HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(3-aminopropyl)(n-butyl)phosphinic acid

interacts preferably with GABA-B RECEPTORS (IC50=38 μM) and GABA-C receptors (IC50=62 μM) over GABA-A RECEPTORS (IC50=508 μM)
Also Known As:
3-aminopropyl-n-butyl phosphinic acid; CGP 36742; CGP-36742; CGP36742; SGS-742; SGS742
Networked: 16 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Froestl, Wolfgang: 3 articles (07/2005 - 10/2004)
2. Gibson, K Michael: 2 articles (11/2021 - 05/2005)
3. Goodwin, Amy K: 2 articles (07/2005 - 05/2005)
4. Weerts, Elise M: 2 articles (07/2005 - 05/2005)
5. Follman, Kristin E: 1 article (05/2022)
6. Morris, Marilyn E: 1 article (05/2022)
7. Austermuehle, Alison: 1 article (11/2021)
8. Cuento, Rose: 1 article (11/2021)
9. Dustin, Irene H: 1 article (11/2021)
10. Inati, Sara K: 1 article (11/2021)

Related Diseases

1. succinic semialdehyde dehydrogenase deficiency
2. Seizures (Absence Seizure)
3. Cognitive Dysfunction
4. Memory Disorders (Memory Loss)
5. Ataxia (Dyssynergia)

Related Drugs and Biologics

1. GABA-B Receptor Antagonists
2. Aminobutyrates (Aminobutyric Acid)
3. gamma-Aminobutyric Acid (GABA)
4. Baclofen
5. Scopolamine (Hyoscine)
6. Acamprosate (Campral)
7. GTP-Binding Proteins (G-Protein)
8. Guanosine 5'-O-(3-Thiotriphosphate)
9. Dronabinol (THC)
10. Prodrugs

Related Therapies and Procedures

1. Oral Administration
2. Therapeutics
3. Electrodes (Electrode)
4. Analgesia
5. Aftercare (After-Treatment)